Keywords: Amarin, Ethyl Eicosapent, EMEA, MA withdrawal, Huntington's disease

Amarin Neuroscience withdraws MA application for Ethyl Eicosapent Soft Capsules

Article | 09 December 2009

The European Medicines Agency (EMEA) says it has been formally notified by Ireland-based Amarin Neuroscience of its decision to withdraw ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in